Biotechnology companies play a vital role in advancing medical innovations and therapies, including breakthroughs and the development of novel therapies for various diseases.
The PRISM Emerging Biotech Index tracks small and micro-cap stocks that are contributing to healthcare innovation and economic growth.
| PRISM Emerging Biotech IndexInception Date of 1/2/2024 at $100.00 | % Change (Daily) | Current Index Value | % Change (Inception) | |||||
|---|---|---|---|---|---|---|---|---|
| 2.6% | $127.80 | 27.8% | ||||||
| Index Components | Ticker | Current Price | % Daily Change | Volume (1,000s) | Average Volume (1,000s) | Market Cap (Millions) | 1/2/2024 Price | % Change Since Inception 1/2/2024 |
| Equillium, Inc. | EQ | $0.65 | 7.993% | 109 | 173 | $23 | $0.73 | -12.1% |
| NeuroBo Pharmaceuticals, Inc. | NRBO | $2.36 | 0.426% | 13 | 43 | $20 | $4.11 | -42.6% |
| Immuron Limited | IMRN | $1.94 | 3.192% | 0 | 8 | $11 | $1.90 | 2.1% |
| Creative Medical Technology Holdings, Inc. | CELZ | $2.11 | -2.315% | 9 | 41 | $4 | $4.60 | -54.1% |
| Kamada Ltd. | KMDA | $6.05 | 0% | 18 | 36 | $348 | $6.16 | -1.8% |
| Achilles Therapeutics plc | ACHL | $1.14 | 16.184% | 2,232 | 129 | $47 | $0.87 | 30.7% |
| Adverum Biotechnologies, Inc. | ADVM | $4.74 | 0% | 57 | 231 | $99 | $0.83 | 472.4% |
| iBio, Inc. | IBIO | $2.44 | 3.404% | 57 | 147 | $22 | $1.38 | 76.8% |
| AIM ImmunoTech Inc. | AIM | $0.19 | 1.729% | 141 | 452 | $12 | $0.48 | -59.8% |
| Palisade Bio, Inc. | PALI | $1.71 | -2.286% | 102 | 1,257 | $5 | $0.58 | 195.4% |
| BioLineRx Ltd. | BLRX | $0.23 | 4.758% | 821 | 1,018 | $22 | $1.53 | -84.7% |
| Immatics N.V. | IMTX | $7.10 | 0.424% | 182 | 626 | $847 | $10.72 | -33.8% |
| Vaxart, Inc. | VXRT | $0.61 | 1.264% | 596 | 1,328 | $138 | $0.61 | 0.0% |
| Capricor Therapeutics, Inc. | CAPR | $14.01 | -0.849% | 334 | 3,192 | $637 | $5.12 | 173.6% |
| Lisata Therapeutics, Inc. | LSTA | $3.10 | 2.483% | 12 | 16 | $26 | $2.78 | 11.3% |
| Quince Therapeutics, Inc. | QNCX | $1.71 | -2.841% | 141 | 573 | $75 | $1.04 | 64.4% |
| NeuroSense Therapeutics Ltd. | NRSN | $1.28 | 2.4% | 360 | 271 | $30 | $0.80 | 60.0% |
| Addex Therapeutics Ltd | ADXN | $7.99 | 2.061% | 1 | 41 | $11 | $6.30 | 26.9% |
| ZyVersa Therapeutics, Inc. | ZVSA | $1.15 | -1.709% | 32 | 1,282 | $3 | $0.88 | 30.7% |
| Metagenomi, Inc. Common Stock | MGX | $3.77 | -5.985% | 656 | 1,802 | $141 | $10.31 | -63.4% |
| 180 Life Sciences Corp. | ATNF | $2.90 | 55.08% | 16,008 | 2,040 | $6 | $3.91 | -25.8% |
| OS Therapies Incorporated | OSTX | $3.85 | 1.852% | 93 | 58 | $82 | $4.41 | -12.7% |
| Klotho Neuroscience Inc. | KLTO | $0.47 | 10.849% | 73 | 523 | $10 | $1.73 | -72.8% |
| Annexon, Inc. | ANNX | $5.23 | -0.947% | 594 | 1,391 | $557 | $4.84 | 8.1% |
| Poseida Therapeutics, Inc. | PSTX | $9.49 | 0.106% | 439 | 1,236 | $925 | $3.38 | 180.8% |
| Rezolute, Inc. | RZLT | $4.41 | -0.676% | 92 | 386 | $256 | $1.02 | 334.5% |
| Foghorn Therapeutics Inc. | FHTX | $5.02 | 1.826% | 48 | 153 | $279 | $8.45 | -40.6% |
| Innate Pharma S.A. | IPHA | $2.06 | -1.905% | 24 | 476 | $171 | $5.72 | -64.0% |
| Chemomab Therapeutics Ltd. | CMMB | $1.71 | 3.824% | 124 | 118 | $32 | $0.54 | 218.5% |
| Plus Therapeutics, Inc. | PSTV | $1.08 | 0.935% | 7 | 92 | $6 | $1.85 | -41.6% |
| Ardelyx, Inc. | ARDX | $4.64 | 1.31% | 3,212 | 4,307 | $1,099 | $6.05 | -23.3% |
| Eupraxia Pharmaceuticals Inc. | EPRX | $3.06 | -1.133% | 0 | 17 | $109 | $4.16 | -26.6% |
| Taysha Gene Therapies, Inc. | TSHA | $1.85 | 1.093% | 926 | 4,361 | $379 | $1.71 | 8.2% |
| Oragenics, Inc. | OGEN | $0.38 | 3.42% | 395 | 801 | $5 | $6.78 | -94.4% |
| Entrada Therapeutics, Inc. | TRDA | $17.56 | 0.573% | 39 | 131 | $657 | $15.17 | 15.8% |
| Akebia Therapeutics, Inc. | AKBA | $1.86 | 0.541% | 510 | 2,028 | $406 | $1.27 | 46.5% |
| Enliven Therapeutics, Inc. | ELVN | $23.15 | -1.195% | 62 | 258 | $1,131 | $14.90 | 55.4% |
| TG Therapeutics, Inc. | TGTX | $32.16 | -0.31% | 496 | 2,938 | $5,006 | $17.04 | 88.7% |
| Myriad Genetics, Inc. | MYGN | $13.74 | 0.659% | 349 | 921 | $1,251 | $19.00 | -27.7% |
| Coya Therapeutics, Inc. | COYA | $5.42 | 1.977% | 14 | 94 | $90 | $6.96 | -22.2% |
| Ocular Therapeutix, Inc. | OCUL | $8.33 | -2.687% | 488 | 1,106 | $1,310 | $4.81 | 73.2% |
| Enlivex Therapeutics Ltd. | ENLV | $1.23 | -0.807% | 44 | 237 | $27 | $3.30 | -62.7% |
| Actuate Therapeutics Inc | ACTU | $7.53 | 10.249% | 56 | 58 | $147 | $8.61 | -12.5% |
| Cardiol Therapeutics Inc. | CRDL | $1.26 | 0.8% | 148 | 489 | $103 | $0.88 | 43.2% |
| Shattuck Labs, Inc. | STTK | $1.11 | 0.909% | 32 | 673 | $53 | $7.56 | -85.3% |
